Skip Navigation

Graduate Summer Institute of Epidemiology and Biostatistics

header

2018 Seminar Series

Current Issues in Epidemiologic Research

June 11 - June 27, 2018
12:30pm to 1:30 pm
Bloomberg School of Public Health

 

Monday, June 11 - Room W5008ADZ

Epidemiology Meets Urban Health: The SALURBAL (Salud Urbana en America Latina/Urban Health in Latin America) Project

Anna Diez Roux, Md, PhD
Dean and Distinguished University Professor of Epidemiology
Drexel University Dornsife School of Public Health

Dr. Diez Roux is internationally known for her research on the social determinants of population health and the study of how neighborhoods affect health. Her work on neighborhood health effects has been highly influential in the policy debate on population health and its determinants.

 

Tuesday, June 12 - Room W5008Celentano

Integrated Care Centers to Reduce HIV Transmission in India - Interim Findings

David Celentano, ScD
Charles Armstrong Chair, Department of Epidemiology
Johns Hopkins Bloomberg School of Public Health

Dr. Celentano's research integrates behavioral science theory and research with epidemiology methods in the study of behavioral and social epidemiology.

 

Wednesday, June 13 - Room W5008DD

Epidemiology for Decision Making: The Case of New Drugs for Tuberculosis

David Dowdy, MD, PhD
Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health

Dr. Dowdy's research interests are dynamic modeling and economic evaluation of TB and TB/HIV, creating modeling frameworks that allow decision-makers to translate epidemiological data into effective decisions, and  improving how these  decisions are implemented in the real world.

 

Thursday, June 14 - Room W5008JH

Childhood Vaccines and the Limits of Observational Evidence

Julian Higgins, PhD
Professor of Evidence Synthesis, University of Bristol School of Social and Community Medicine

Dr. Higgin's wide-ranging research interests span all areas of systematic review and meta-analysis research. Some of his research contributions are: a Bayesian approach to network meta-analysis; a general framework for individual participant data meta-analysis;  and risk-of-bias assessment tools for clinical trials and other study designs

 

Friday, June 15 - Room W5030hofman

The Alzheimer Enigma: The Causes of the Dementia Epidemic

Albert Hofman, MD, PhD
Chair, Department of Epidemiology, Harvard T.H. Chan School of Public  Health

Dr. Hofman is the initiator and principal investigator of two population based, prospective cohort studies: the Rotterdam Study and the Generation R study. The study of a multiple outcomes, in particular neurological, cardiovascular and endocrine diseases, has enabled the investigation of the interrelations of those diseases.

 

Monday, June 18 - Room W5030Kuller

Dementia is not a Disease! Need Biomarkers and Specificity for Epidemiological Research

Lewis Kuller, MD, DrPH
Professor, Department of Epidemiology, University of Pittsburgh School of Public Health

Dr. Kuller is nationally recognized for his contributions in the study of cardiovascular disease and the use of non-invasive techniques such as ultrasound, to detect early heart disease in people without symptoms.

 

Tuesday, June 19 - Room W5030AM

Post-Traumatic Stress Disorder and Cardiovascular Diseases: A Cohort Study of Men and Women  involved in Cleaning the Debris  of the World Trade Center Complex

Alfredo Morabia, MD, PhD
Professor, Department of Epidemiology
Columbia University Mailman School of Public Health

Dr.  Morabia lectures and teaches on the history of epidemiology internationally, and also serves as the Editor in Chief of the AJPH (former American Journal of Public Health).

Wednesday, June 20 - Room W5030Richey

Conceptual Overview of the Aging Process and Implications for Epidemiology

Richey Sharrett, MD, DrPH
Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health

Dr. Sharrett is a cardiovascular epidemiologist with a major interest in vascular cognitive impairments.

 

Thursday, June 21 - Room W5008NM

The Microbiome and Metabolic Diseases: In Pursuit of Causality

Noel Mueller, PhD
Assistant Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health

Dr. Mueller is interested in the prevention of obesity, type 2 diabetes, and cardiovascular disease from the perspectives of life course, nutritional and microbiome epidemiology. His research aims to identify early-life, modifiable antecedents of cardiometabolic disease in diverse populations locally and globally

 

Friday, June 22  - Room W5008Km

New Epidemiological Insights of Peripheral Artery Disease

Kunihiro Matsushita, MD, PhD
Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health

Dr. Matsushita investigates the associations among kidney, diabetes, and cardiovascular disease associations using the Atherosclerosis Risk in Communities (ARIC) Study and a recently developed collaboration, Chronic Kidney Disease (CKD) Prognosis Consortium (http://www.jhsph.edu/ckdpc).

 

Monday, June 25 -Room W5008cooper

Precision Medicine - Can it Cross the Bridge to Public Health and Clinical Relevance

Richard Cooper,  MD
Professor, Department of Public Health Sciences
Loyola University Stritch Medical School

Dr. Cooper is a cardiovascular epidemiologist with a long-term interest in hypertension and related conditions in populations of African origin. His work has demonstrated the determining role of changing environmental conditions on the evolution of cardiovascular risk status
 

Tuesday, June 26 -Room W5030

Beyond the Summer Institute: Educational Opportunities at JHSPH

 JHSPH Faculty

 

Wednesday, June 27 - Room 5030LC

Social Epidemiology to Inform Health Equity Interventions

Lisa Cooper, MD
Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health

Dr. Lisa Cooper is a general internist, social epidemiologist, and health services researcher. She was one of the first scientists to document disparities in the quality of relationships between physicians and patients from socially at-risk groups.